Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Appili Therapeutics Inc. (APLIF) had Free Cash Flow per Share of $-0.01 for the most recently reported fiscal year, ending 2026-03-31.
| Income Statement Financials | |
$0.18M |
|
$-3.07M |
|
-- |
|
$0.18M |
|
$4.90M |
|
$-4.72M |
|
$1.73M |
|
$-2.99M |
|
$-2.99M |
|
$-3.07M |
|
$-3.07M |
|
$-3.07M |
|
$-3.07M |
|
$-4.72M |
|
$-4.72M |
|
123.72M |
|
123.72M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$1.42M |
|
$0.01M |
|
$0.01M |
|
$1.43M |
|
$13.49M |
|
$0.49M |
|
$0.49M |
|
$13.97M |
|
$-12.54M |
|
$-12.54M |
|
$-12.54M |
|
132.37M |
|
| Cash Flow Statement Financials | |
$-0.97M |
|
-- |
|
$0.11M |
|
$0.89M |
|
$0.03M |
|
$-0.86M |
|
$0.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.11 |
|
-- |
|
-- |
|
-0.04 |
|
-0.75 |
|
100.00% |
|
-2672.16% |
|
-2672.16% |
|
-2668.84% |
|
-1693.59% |
|
-1736.73% |
|
$-0.97M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
-- |
|
0.14 |
|
2693.42 |
|
24.47% |
|
24.47% |
|
-214.89% |
|
25.45% |
|
$-0.09 |
|
|
Free Cash Flow per Share |
$-0.01 |
$-0.01 |
|